0001183740-19-000021.txt : 20190131 0001183740-19-000021.hdr.sgml : 20190131 20190131164329 ACCESSION NUMBER: 0001183740-19-000021 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190131 DATE AS OF CHANGE: 20190131 EFFECTIVENESS DATE: 20190131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ProMIS Neurosciences Inc. CENTRAL INDEX KEY: 0001374339 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-331888 FILM NUMBER: 19556374 BUSINESS ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 BUSINESS PHONE: 416-847-6898 MAIL ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 FORMER COMPANY: FORMER CONFORMED NAME: AMORFIX LIFE SCIENCES LTD DATE OF NAME CHANGE: 20060831 D 1 primary_doc.xml X0708 D LIVE 0001374339 ProMIS Neurosciences Inc. SUITE 200, 1920 YONGE STREET TORONTO A6 ONTARIO, CANADA M4S 3E2 4153415783 CANADA (FEDERAL LEVEL) AMORFIX LIFE SCIENCES LTD Corporation true Elliot Goldstein Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director Eugene Williams Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director William Wyman Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Johannes Roth Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Patrick Kirwin Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Neil Cashman Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director Richard Gregory Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Anthony Giovinazzo Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Daniel E. Geffken Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Johanne Kaplan Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Biotechnology Decline to Disclose 06b false 2019-01-22 true true true true true 690,231 Units at US$0.173 per Unit (comprised of one common share and one common share purchase warrant, exercisable into a share at C$0.48 until Jan 22, 2024, subject to acceleration). false 0 367893 119409 248484 Total Offering Amount equals price of Units (690,231 x $0.173) plus exercise price of the underlying Warrants (690,231 Warrants x $0.36 (C$0.48)). There is no guarantee that the Warrants, expiring Jan 22, 2024, will be exercised. false 4 0 0 0 false ProMIS Neurosciences Inc. /s/ Elliot Goldstein Elliot Goldstein CEO and President 2019-01-30